Literature DB >> 23419659

Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success.

Thomas Neumann1, Maciej Wójcik, Alexander Berkowitsch, Damir Erkapic, Sergey Zaltsberg, Harald Greiss, Dimitri Pajitnev, Stefan Lehinant, Jörn Schmitt, Christian W Hamm, Heinz F Pitschner, Malte Kuniss.   

Abstract

AIMS: Long-term efficacy following cryoballoon (CB) ablation of atrial fibrillation (AF) remains unknown. This study describes 5 years follow-up results and predictors of success of CB ablation in patients with paroxysmal atrial fibrillation (PAF). METHODS AND
RESULTS: In total, 163 patients were enrolled with symptomatic, drug refractory PAF. Pulmonary vein isolation (PVI) with CB technique was performed. Primary endpoint of this consecutive single-centre study was first electrocardiogram-documented recurrence of AF, atrial tachycardia or atrial flutter (AFLAT). Five years success rate after single CB ablation was 53%. In 70% of the patients acute complete PVI was achieved with a single 28 mm balloon. The univariate predictors of AFLAT recurrence were (1) size of left atrium, with normalized left atrium (NLA) ≥10.25 [hazard ratios (HR) of 1.81, 95% confidence interval (CI): 1.28-2.56] when compared with NLA <10.25 (35% vs. 53%, P = 0.0001) and (2) renal function, with impaired glomerular filtration rate (GFR) <80 ml/min (HR of 1.26, 95% CI: 1.02-1.57) when compared with GFR ≥80 ml/min (45% vs. 53%, P = 0.041). Normalized left atrium ≥10.25 was the sole independent predictor for outcome (HR 2.11; 95% CI: 1.34-3.31; P = 0.0001).
CONCLUSIONS: Sinus rhythm can be maintained in a substantial proportion of patients with PAF even 5 years after circumferential PVI using CB ablation. The rate of decline in freedom from AFLAT was highest within the first 12 months after the index procedure. The patients with enlarged left atrium and/or impaired renal function have lower outcome.

Entities:  

Keywords:  Ablation; Arrhythmia; Catheter ablation; Cryoballoon; Long-term follow-up; Paroxysmal atrial fibrillation; Pulmonary vein isolation; Tachyarrhythmias

Mesh:

Year:  2013        PMID: 23419659     DOI: 10.1093/europace/eut021

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  28 in total

1.  The novel human gene aprataxin is directly involved in DNA single-strand-break repair.

Authors:  P Mosesso; M Piane; F Palitti; G Pepe; S Penna; L Chessa
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 2.  [Pulmonary vein isolation for atrial fibrillation : Findings from long-term follow-up].

Authors:  C-H Heeger; K-H Kuck; F Ouyang
Journal:  Herz       Date:  2017-06       Impact factor: 1.443

3.  Coronary sinus catheter placement via left cubital vein for phrenic nerve stimulation during pulmonary vein isolation.

Authors:  Akio Chikata; Takeshi Kato; Kazuo Usuda; Shuhei Fujita; Michiro Maruyama; Kan-Ichi Otowa; Shin-Ichiro Takashima; Hisayoshi Murai; Soichiro Usui; Hiroshi Furusho; Shuichi Kaneko; Masayuki Takamura
Journal:  Heart Vessels       Date:  2019-04-10       Impact factor: 2.037

4.  A long-term evaluation of cryoballoon ablation in 205 atrial fibrillation patients: a single center experience.

Authors:  Alexander Bohó; Silvia Mišíková; Peter Spurný; Erika Komanová; Michal Kerekanič; Marek Hudák; Branislav Stančák
Journal:  Wien Klin Wochenschr       Date:  2015-07-04       Impact factor: 1.704

Review 5.  Durable Pulmonary Vein Isolation: The Holy Grail of Atrial Fibrillation Ablation.

Authors:  Duy Thai Nguyen; William H Sauer
Journal:  J Atr Fibrillation       Date:  2013-10-31

Review 6.  Connexin Remodeling Contributes to Atrial Fibrillation.

Authors:  Michelle M Jennings; J Kevin Donahue
Journal:  J Atr Fibrillation       Date:  2013-08-31

7.  Five-year clinical outcomes of visually guided laser balloon pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation.

Authors:  Bruno Reissmann; Thorsten Budelmann; Erik Wissner; Michael Schlüter; Christian-Hendrik Heeger; Shibu Mathew; Tilman Maurer; Christine Lemes; Thomas Fink; Andreas Rillig; Francesco Santoro; Johannes Riedl; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner
Journal:  Clin Res Cardiol       Date:  2017-12-28       Impact factor: 5.460

8.  Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Authors:  Florian Straube; Uwe Dorwarth; Stefan Hartl; Benedikt Bunz; Michael Wankerl; Ullrich Ebersberger; Ellen Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2015-12-23       Impact factor: 1.900

9.  Impact of Pulmonary Vein Anatomy on Long-term Outcome of Cryoballoon Ablation for Atrial Fibrillation.

Authors:  Shang-Wei Huang; Qi Jin; Ning Zhang; Tian-You Ling; Wen-Qi Pan; Chang-Jian Lin; Qing-Zhi Luo; Yan-Xin Han; Li-Qun Wu
Journal:  Curr Med Sci       Date:  2018-04-30

10.  Long-term outcome after second-generation cryoballoon ablation for paroxysmal atrial fibrillation - a 3-years follow-up.

Authors:  Ken Takarada; Ingrid Overeinder; Carlo de Asmundis; Erwin Stroker; Giacomo Mugnai; Valentina de Regibus; Darragh Moran; Hugo Coutino-Moreno; Juan-Pablo Abugattas; Rajin Choudhury; Diego Ruggiero; Gaetano Paparella; Saverio Iacopino; Pedro Brugada; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2017-03-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.